Literature DB >> 33796388

Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India.

Mala Mahto1, Ayan Banerjee1, Bijit Biswas2, Sushil Kumar1, Neeraj Agarwal2, Prabhat Kumar Singh3.   

Abstract

Healthcare workers (HCWs) due to their job profile are at utmost risk of contracting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Serological survey is an useful tool for vulnerability mapping in an infectious disease pandemic. The aim of the current study was to assess seroprevalence of IgG against SARS-CoV-2 and its determinants among HCWs of a tertiary healthcare facility of India. It was an observational study, cross-sectional in design conducted among 919 HCWs of All India Institute of Medical Sciences, Patna, Bihar, India during September, 2020. In results, IgG seroprevalence for SARS-CoV-2 among the study subjects was 13.3% [95% confidence interval (CI): 11.2-15.6%]. In univariate logistic regression analysis; gender, occupation, place of posting, use of full personal protective equipment (PPE), prior corona virus disease (COVID)-19 infection, influenza like illness (ILI), use of steam inhalation, consumption of azithromycin, zinc and vitamin C were the significant attributes which affected the IgG seropositivity for SARS-CoV-2. In the multivariable logistic regression model; occupation, place of posting, prior COVID-19 infection and ILI were significant determinants of IgG seropositivity for SARS-CoV-2. To conclude, majority of the HCWs were found to be IgG seronegative for SARS-CoV-2. Till availability of effective vaccine all of the HCWs should abide by infection prevention and control (IPC) measures to keep themselves and their contacts protected from SARS-CoV-2. AJBR
Copyright © 2021.

Entities:  

Keywords:  COVID-19; epidemiologic factors; health personnel; immunoglobulin G; seroepidemiologic studies

Year:  2021        PMID: 33796388      PMCID: PMC8010601     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  5 in total

Review 1.  Factors associated with differential COVID-19 mortality rates in the SEAR nations: a narrative review.

Authors:  Rubina Mulchandani; Giridhara R Babu; Avinash Kaur; Ranjana Singh; Tanica Lyngdoh
Journal:  IJID Reg       Date:  2022-02-27

Review 2.  Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.

Authors:  Nuzrath Jahan; Adarsha Brahma; Muthusamy Santhosh Kumar; Bhavani Shankara Bagepally; Manickam Ponnaiah; Tarun Bhatnagar; Manoj V Murhekar
Journal:  Int J Infect Dis       Date:  2021-12-28       Impact factor: 12.074

3.  Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.

Authors:  Rrezart Halili; Jeta Bunjaku; Bujar Gashi; Teuta Hoxha; Agron Kamberi; Nexhmedin Hoti; Riaz Agahi; Vlora Basha; Visar Berisha; Ilir Hoxha
Journal:  BMC Infect Dis       Date:  2022-01-16       Impact factor: 3.090

4.  Sero-epidemiological survey of SARS-Cov2 in urban slums of a capital city: A cross- sectional study.

Authors:  Santosh K Nirala; Bijaya N Naik; Neha Chaudhary; Alok Ranjan; Mala Mahto; Sanjay Pandey; Chandra Mani Singh; Prabhat K Singh
Journal:  J Family Med Prim Care       Date:  2022-06-30

5.  Epidemiological Algorithm for Early Detection of COVID-19 Cases in a Mexican Oncologic Center.

Authors:  Moisés González-Escamilla; Diana Cristina Pérez-Ibave; Carlos Horacio Burciaga-Flores; Vanessa Natali Ortiz-Murillo; Genaro A Ramírez-Correa; Patricia Rodríguez-Niño; Rafael Piñeiro-Retif; Hazyadee Frecia Rodríguez-Gutiérrez; Fernando Alcorta-Nuñez; Juan Francisco González-Guerrero; Oscar Vidal-Gutiérrez; María Lourdes Garza-Rodríguez
Journal:  Healthcare (Basel)       Date:  2022-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.